| Literature DB >> 23601924 |
Begoña Bedrina1, Sonia Macián, Inmaculada Solís, Roberto Fernández-Lafuente, Eva Baldrich, Guillermo Rodríguez.
Abstract
BACKGROUND: Legionellosis is an uncommon form of pneumonia. After a clinical encounter, the necessary antibiotic treatment is available if the diagnosis is made early in the illness. Before the clinical encounter, early detection of the main pathogen involved, Legionella pneumophila, in hazardous environments is important in preventing infectious levels of this bacterium. In this study a qualitative test based on combined magnetic immunocapture and enzyme-immunoassay for the fast detection of Legionella pneumophila in water samples was compared with the standard method, in both comparative and collaborative trials. The test was based on the use of anti-Legionella pneumophila antibodies immobilized on magnetic microspheres. The final protocol included concentration by filtration, resuspension and immunomagnetic capture. The whole assay took less than 1 hour to complete.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23601924 PMCID: PMC3637370 DOI: 10.1186/1471-2180-13-88
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Comparison of the immunomagnetic method with the standard culture method
| | ||||
| Culture method (ISO 11731) | + | ― | + | ― |
| + | 284 | 10 | 284 | 10 |
| ― | 20 | 145 | 0 | 165 |
a Presumptive IMM results.
b Confirmed IMM results.
Summary of immunomagnetic test and ISO reference method results for the estimation of LOD
| 1 | 0 | 0/6 |
| 2 | 3.4 | 0/10 |
| 3 | 15.1 | 14/30 |
| 4 | 20.4 | 7/10 |
| 5 | 68.3 | 10/10 |
determination in collaborative trial, Log (CFU/9 mL) (by participant no.)
| | | |||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| | | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 0 | P6 | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | A | A | A | A | A | A | A | A | A | A | A |
| | P8 | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | A | A | A | A | A | A | A | A | A | A | A |
| 2.23 | P4 | 2.83 | 2.22 | 2.21 | 2.47 | 2.57 | 2.11 | 2.38 | 2.23 | 2.73 | 1.98 | 2.32 | 3.0 | <3.0 | 3.0 | <3.0 | <3.0 | <3.0 | 2.0 | 2.0 | 3.0 | 2.0 | 3.0 | P | P | P | P | P | P | P | P | P | P | P |
| | P7 | 2.11 | 2.16 | 2.36 | 2.25 | 2.13 | 2.11 | 2.10 | 2.01 | 2.17 | 1.90 | 2.32 | <4.0 | <3.0 | <4.0 | <4.0 | <3.0 | 3.0 | 3.0 | 2.0 | <4.0 | 2.0 | 3.0 | P | P | P | P | P | P | P | P | P | P | P |
| 2.88 | P1 | 3.07 | 2.86 | 3.12 | 3.19 | 3.04 | 1.99 | 2.99 | 2.96 | 2.69 | 2.78 | 2.85 | 4.0 | 3.0 | 3.0 | <4.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | P | P | P | P | P | P | P | P | P | P | P |
| | P3 | 3.13 | 2.90 | 3.11 | 3.13 | 3.07 | 2.29 | 2.61 | 2.51 | 2.77 | 2.57 | 2.77 | 3.0 | 3.0 | 3.0 | <4.0 | 3.0 | 2.0 | 3.0 | 2.0 | <4.0 | 3.0 | 3.0 | P | P | P | P | P | P | P | P | P | P | P |
| 3.82 | P2 | 4.01 | 4.23 | 4.03 | 3.93 | 3.76 | 3.59 | 3.49 | 3.56 | 3.21 | 3.59 | 4.22 | 4.0 | >4.0 | >4.0 | <4.0 | 4.0 | >4.0 | 4.0 | 3.0 | 4.0 | >4.0 | 4.0 | P | P | P | P | P | P | P | P | P | P | P |
| | P5 | 3.92 | 4.20 | 4.30 | 3.64 | 3.63 | 3.94 | 3.77 | 3.66 | 3.97 | 3.61 | 3.95 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | >4.0 | 4.0 | 3.0 | 4.0 | >4.0 | >4.0 | P | P | P | P | P | P | P | P | P | P | P |
| P9 | 3.33 | 4.20 | 3.91 | 3.89 | 3.92 | 3.71 | 3.48 | 3.63 | 3.97 | 2.91 | 3.99 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | >4.0 | >4.0 | >4.0 | 3.0 | 4.0 | 4.0 | P | P | P | P | P | P | P | P | P | P | P | |
a This table includes only results from participating laboratories that were not excluded due to obvious deviation from the trial protocol.
b Concentrations calculated from the results provided by the 11 participating laboratories, assigned to the used reference materials (pills).
c ND, not detected.
d A, absence; P, presence.